Curated News
By: NewsRamp Editorial Staff
April 17, 2025
Nutriband CEO Gareth Sheridan Named Finalist in EY Entrepreneur of the Year Awards
TLDR
- Nutriband CEO Gareth Sheridan named finalist in 2025 EY Entrepreneur of the Year Awards, showcasing leadership in life sciences sector.
- Sheridan transformed Nutriband into a U.S.-listed company focused on transdermal drug delivery and abuse-deterrent technologies with lead product AVERSA.
- AVERSA technology by Nutriband addresses critical pain management gaps, aiming to prevent misuse and abuse of opioid patches for a better future.
- 27 Irish entrepreneurs, including CEO Gareth Sheridan, to compete for overall Entrepreneur of the Year title at gala event in November, showcasing innovation.
Impact - Why it Matters
This news highlights the recognition of Nutriband's CEO for his leadership in transforming the company and developing innovative solutions to address opioid misuse. It showcases the importance of entrepreneurship and innovation in the life sciences sector, ultimately impacting the future of drug delivery technology and abuse prevention.
Summary
Nutriband (NASDAQ: NTRB) CEO Gareth Sheridan named finalist in the 2025 EY Entrepreneur of the Year Awards for transforming Nutriband into a life sciences company focusing on transdermal drug delivery. Sheridan recognized for leading the development of AVERSA, a patch designed to prevent opioid misuse.
Finalists in the EY program will compete for the overall Entrepreneur of the Year title, to be awarded at a gala event in November. Nutriband is primarily engaged in the development of transdermal pharmaceutical products, with AVERSA technology aimed at deterring abuse of drugs with potential for misuse.
Source Statement
This curated news summary relied on this press release disributed by InvestorBrandNetwork (IBN). Read the source press release here, Nutriband CEO Gareth Sheridan Named Finalist in EY Entrepreneur of the Year Awards
